Lotel Ls 0.2% Bottle Of 5ml Eye Drops
5ml Eye Drop in BottleMRP ₹169.50
₹118.65
30% OFF
Made by
AJANTA PHARMA LIMITED
Dosage
EYE DROP
Expiry
Product Summary
| Salt Content | Loteprednol(0.2 %W/V) |
| Uses | Dry Eye, Allergic conjuctivitis |
| Therapy | Occular steroid |
| Side effects | Watery eyes, Eye irritation, Itchy eyes, Burning, Headache |
Assurance
available
Regulated
Medical Description
Uses
- Dry Eye
- Allergic conjuctivitis
- Post operative ocular inflammation
Contraindications
- Infections caused by virus, bacteria and fungi
- Contact lens wear
- Glaucoma
- Cataract
Side effects
- Watery eyes
- Eye irritation
- Itchy eyes
- Burning
- Headache
Precautions and Warnings
Pregnancy
Breast Feeding
Driving
Alcohol
Other General Warnings
- You have cataract or glaucoma in the past
- You are allergic to Loteprednol
Directions for Use
Storage and disposal
Dosage
Overdose
Missed a Dose
Mode of Action
How Does It Work?
Interactions
Interactions with other medicines
- Loteprednol Etabonate may react with Flurbiprofin (opthalmic), latanoprost, diclofenac (opthalmic) and may hinder with their effect.
- This medicine may react with corbicistat, ritonavir and may hinder the anti-HIV effect of these medicines.
- Loteprednol Etabonate should not be given with smallpox vaccine and antibiotics like Clarithromycin as this may alter their respective effects.
Other general Interactions
Frequently Asked Questions (FAQs)
Articles
View All
Chronic Condition Articles
View All
Did you find this helpful?
Explore More at Pharmeasy
Manufacturer Details
Brand:LOTEL
Manufacturer Name:AJANTA PHARMA LIMITED
Address:<p>1. Ajanta House, Charkop, Kandivli West, Mumbai 400 067, India</p>
Country of Origin:India
Vendor Details
Fulfillment Information: Lotel Ls 0.2 %W/V Eye Drop (5) will be delivered by a licensed retail pharmacy nearest to your location. Order acceptance and fulfillment are dependent upon the verification of your doctor's valid prescription (where applicable) and the current stock of this medicine.
References:
- LOTEMAX® (loteprednol etabonate ophthalmic gel) 0.5% [Internet]. Accessdata.fda.gov. 2022 [cited 17 March 2022]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202872lbl.pdf
- Beckman K, Katz J, Majmudar P, Rostov A. Loteprednol Etabonate for the Treatment of Dry Eye Disease. Journal of Ocular Pharmacology and Therapeutics. 2020;36(7):497-511.
In Case of Any Issues Contact Us
Email Id:care@pharmeasy.in
Phone Number:7666100300
Address:D-37/1, Opp. Sandoz, TTC Industrial Area, MIDC Industrial Area, Turbhe, Navi Mumbai, Maharashtra 400703
Disclaimer
The information provided herein is supplied to the best of our abilities to make it accurate and reliable as it is published after a review by a team of professionals. This information is solely intended to provide a general overview on the product and must be used for informational purposes only. You should not use the information provided herein to diagnose, prevent, or cure a health problem. Nothing contained on this page is intended to create a doctor-patient relationship, replace or be a substitute for a registered medical practitioner's medical treatment/advice or consultation. The absence of any information or warning to any medicine shall not be considered and assumed as an implied assurance. We highly recommend that you consult your registered medical practitioner for all queries or doubts related to your medical condition. You hereby agree that you shall not make any health or medical-related decision based in whole or in part on anything contained in the Site. Please click here for detailed T&C.
